CH
Insider
Carole Huntsman
Chief Commercial OfficerCarole Huntsman (Chief Commercial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $715K of MDGL (1,294 sh across 3 lots, as filed), executed Nov 21 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Mar 6
Filed Mar 6
Median ADV $194.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
MDGLRecent filings
MDGLSALE
Madrigal Pharmaceuticals, Inc.
View filing →
$181K419 sh × $431.94
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $449K
910 sh across 2 lots
Exec Jan 26
Filed Jan 26 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $715K
1,294 sh across 3 lots
Exec Nov 21 2025
Filed Nov 21 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $189K
563 sh × $335.00
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $116K
347 sh × $335.24
Exec Jan 24 2025
Filed Jan 27 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $218K
688 sh × $316.92
Exec Nov 21 2024
Filed Nov 22 2024 · 5:30 PM ET